Read the latest papers on Breast Cancer across BMC flagship journals.
Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial
Joaquin Gavila et al.
Published in BMC Medicine 09 January 2019
Published in BMC Biology 02 October 2018
Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
Elen Kristine Hoglander et al.
Published in Genome Medicine 29 November 2018
VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer
Andrew N. Holding et al.
Published in Genome Biology 13 May 2019